Clinical Study
Two-Stage Revision TKA Is Associated with High Complication and Failure Rates
Table 4
Risk factors for failure: organisms.
| | Fraction with failure, (%) | RR | 95% CI | value |
| Streptococcus | | 3.18 | 2.13–4.72 | <0.001 | Yes | 4/4 (100%) | | | | No | 17/54 (32%) | | | |
| MSSA | | 1.26 | 0.63–2.53 | 0.510 | Yes | 8/19 (42%) | | | | No |
13/39 (33%) | | | |
| MRSA | | 0.77 | 0.22–2.64 | 0.674 | Yes | 2/7 (29%) | | | | No | 19/51 (37%) | | | |
| Coagulase negative Staphylococcus | | 0.88 | 0.42–1.84 | 0.737 | Yes | 7/21 (33%) | | | | No | 14/37 (38%) | | | |
| Polymicrobial | | 3.31 | 2.19–5.00 | <0.001 | Yes | 5/5 (100%) | | | | No | 16/53 (30%) | | | |
|
|